Zoll Medical Corporation, which received FDA clearance a few years ago for both home and hospital versions of its wearable defibrillator LifeVest, is now dealing with a range of lawsuits and FDA ...

ESC Heart Failure Late Breaker: Largest single LifeVest® WCD study of NICM and MI/CAD patients shows high appropriate treatment rates during early period of contemporary GDMT CHELMSFORD, ...

Only LifeVest has >95% first shock success in peer-reviewed publications and real-world use, 2-5 96% one-year survival data, 6 and a wealth of published research covering more than 120,000 patients. 2 ...